Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 10/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 7/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.39 |
| ▸ | FAP | Q12884 | 4/20 | 0.39 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13071561 | 0.88 | DPP4 (0.39) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL13071679 | 0.84 | DPP4 (0.39) | DPP4DPP7DPP8DPP9ACE | |
| SCHEMBL8266621 | 0.83 | DPP4 (0.44) | DPP4 | |
| SCHEMBL13071454 | 0.83 | DPP4 (0.33) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL12831740 | 0.82 | OPRM1 (0.34) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL6124816 | 0.81 | F2 (0.44) | ACE | |
| SCHEMBL12784272 | 0.79 | DPP7 (0.46) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL13071458 | 0.79 | DPP8 (0.38) | DPP4DPP8ACE | |
| SCHEMBL13071921 | 0.76 | DPP4 (0.35) | DPP4ACE | |
| SCHEMBL12831734 | 0.75 | DPP4 (0.33) | DPP4DPP7DPP8DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009142842-A9 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| WO-2009142842-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2009-11-26 | — | — | WO | disclosed |